Researchers at Case Western Reserve University have identified a microRNA biomarker that shows promise in predicting treatment response in the most common form of ovarian cancer—a breakthrough that has the potential to improve outcomes for patients with the disease. A Case Comprehensive Cancer Center research team led by Analisa DiFeo, […]
BioMotiv, a drug development accelerator based in Cleveland, and the Icahn School of Medicine at Mount Sinai, based in New York, are announcing the formation of Dual Therapeutics, a company focused on producing therapeutics for prostate cancer, lung cancer, and acute lymphoblastic leukemia. Dual Therapeutics is based on intellectual property […]
Award winning Chef Floyd Cardoz of North End Grill talks about his reasons for starting The Young Scientist Foundation at the First Annual YSF Gala, held on March 11, 2013 at North End Grill in New York City.
Daniel McQuaid, a student whose research continues to be sponsored by The Young Scientist Foundation, was among 40 finalists in the nationwide Intel Science Search, held in early 2013. Cited from: http://www.nytimes.com/interactive/2013/03/11/science/intel-science-talent-search-finalists-talk-science.html
Caroline Farrington, currently a graduate student at Case Western Reserve University in Cleveland, Ohio, discusses her experiences and the positive impact The Young Scientist Foundation has had on her research career at the First Annual YSF Gala, held on March 11, 2013 at North End Grill in New York City.
A $250 million drug discovery initiative launched last year at University Hospitals of Cleveland has produced its second startup, this one based on cancer research from the Icahn School of Medicine at Mount Sinai. Dual Therapeutics will develop new treatments for prostate cancer, lung cancer and acute lymphoblastic leukemia, according to an […]
The Mary Kay Foundation 2013 Cancer Grant Recipients YSF Board Member Analisa DiFeo, Ph.D., Case Western Reserve University, Cleveland, OH Title of Project: Single Agent Dual Inhibition of the AKT and ERK Signaling Pathway for the Treatment of Ovarian Cancer David K. Ann, Ph.D., City of Hope, Los Angeles, CA […]
Crain’s is proud to honor these dedicated heroes for their achievements and outstanding level of care that enriches everyday life. Awards Luncheon: Tuesday, May 21 • 1:00am-1:30pm 2013 Health Care Heroes Award Recipients Administrator of the Year • Nursing: Catherine Koppelman, Chief Nursing Officer; University Hospitals • Hospital: Cynthia Moore-Hardy, […]
Dr. Goutham Narla and his team have found that by using a combination of two FDA approved drugs – Erlotinib and Trifluoperazine – a process that is causing lung tumor cells to die can be initiated. A team of researchers led by Dr. Goutham Narla at Case Western Reserve University […]
Class of 2016 Blake Smith has worked in cell biology labs since he was 16, first at Mount Sinai School of Medicine and now at Yale Medical School. As a high school junior, he won first place in the category of Cellular and Molecular Biology at the Intel International Science […]